{"nct_id":"NCT00877006","title":"Study of Bendamustine Hydrochloride and Rituximab (BR) Compared With R-CVP or R-CHOP in the First-Line Treatment of Patients With Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL) - Referred to as the BRIGHT Study","status":"COMPLETED","status_verified_date":"2018-01","start_date":"2009-04-30","start_date_type":null,"primary_completion_date":"2012-03-31","primary_completion_date_type":"ACTUAL","completion_date":"2012-03-31","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["TEVA"]}